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Free amino acid cnan\iomcrs in adult ral brain cxuxcls wcx analyzed as lhcir N,Oqxntalluoropropionyl isopropyl derivatives by guschroma~og- 
raphy on a capillary column or Chirasil-L-Val. A peak X. which rxhibhcd the same rctcntion lime as the N.O-pemalluoropropionyl isopropyl 
derivative ot’authcnlic D-scrinu. wus dclcctod in lhe brain cxlracts. Electron impact and posilivc chcmicill ioni&on muss spectra of the peak X 
oi the brain cxlracls were idcniical to those or authentic D-scrinc. The concentration of free D-scrinc und lhu rutio of D-scrinc/lolal scrinc in the 
brain wcrc cstimalcd to bc 0.27 and 0.23 ymol/g of WCL wciyht. rcspcctivcly, Thcsc dalu provide the lirst evidence that substanlial quanlitics of 
rrec D-scrinc arc prcacnt in mammalian brain tissues. 
D-Scrinc; Amino acid cnuntiomer; Cbirusil-L-W; Gas chromatography; Mass spcclromciry: Rat brain 
I, INTRODUCTION 
Several lines of evidence have demonstrated that D- 
amino acids such us D-serine and D-alanine potentiate 
IV-methyl-D-aspartate (NM DA)-type excitatory amino 
acid receptor-mediated response through interaction 
with the strychnine-insensitive glycine binding site in 
mammalian brains in vitro [l-3]. Furthermore, an intra- 
cerebroventricular administration of these D-amino 
acids enhances the NMDA-induced seizure suscepti- 
bility [4] and inhibits phencyclidine- and methamphe- 
tamine-induced locomotor stimulation and stereotyped 
behaviors in rats [S-7]. Despite these significant func- 
tional roles in the central nervous system, the presence 
of free D-amino acids in mammalian brain has not yet 
btien demonstrated, with the exception of the small 
amounts of free neutral amino acids in mice and human 
brains [8,9] and of free D-aspartate in adult rat and 
human brains (less than 3% of total aspartate) [l&12]. 
In the present study, we report the identification and the 
concentration of the free D-enantiomer of serine in 
adult rat brain using gas chromatographic (GC) analy- 
Ablmtviurionx GC, gas chromalograpby; MS, mass spL~tromelry: 
PFPA. penlalluoropropionic anhydride; TCA, lrichloroacctic acid; 
El. electron-impact ionization; PCI. positive chemical ionization: 
NMDA, N-metIlyl-D-aspurlalc; L-NL, L-norleucinc. 
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sis and (X-electron-impact (El)- and positive chemical 
ionization (Xl)-mass spectroscopic (MS) analyses. 
2. MATERIALS AND METHODS 
All amino acids and trichloroacctic acid (TCA) were oblainrd rrom 
Nakardi Tcsquc (Japan). All solvcnls were HPLC grade and pur- 
chased from Kanto Chemicals (Japan). A pcntafluoropropionic an- 
hydride (PFPA) was purchased from G.L.C. Scicncc (Japun). 
Amino acid slack solutions were prcparcd by dissolving amino acids 
in 0.01 M HCI 10 a conccnlralion of IO~mol/ml CXII. The: s1andard 
amino ncid slack solutions aiicr approprialc dilution with 0.01 M HCI 
wcrc used for culibralion. L-Norlcucinc (L-NL) was used as an inlcr- 
nul slantlard. 
The gas chromatogrdphic analysis was carried OUI using a Hcwlc~~ 
Packard 5890 (Hewlet Packard, Japan) cyuippcd with nilrogun- 
phosphorus dclector. SumpIes wcrr! analyzed on a Chiresil-L-Vu1 
capillary column (35 m x 0.25 mm, film thickness 0. I2 Elm. Gasukuro 
Kogyo. Japan). 
The chromalogrnphic conditions were: injection tempcraturc. 
250°C; dclcclor tcmpcrature, 3OWC: Wmpcraturc program. 80°C 
isolhcrmal for 5 min, then SO-140°C al 2’Qmin and split ratio. l:lO. 
The column head pressure was I IO kPa. and the helium flow-mu on 
the column was 0.4 ml/min; the flow-rate (plus auxiliary gas) was 30 
mllmin. The hydrogen flow-ralc and the air flow-rate al the dctcctor 
were 3.5 and I IO ml/min, rcspcctivcly. Peak arca was dclcrmined using 
a SIC chromalocorder I I intcgralor (Syslcm Inslrumcnu Co.). 
2.3. rWS umi/~v.si,s 
The GC-MS analysis was pcrrormcd on a V.G. Masslab Trio-l mass 
spectrometer (Jasco, ImcrnaGonal Co., Japan), equipped with a 
Hcwlcu Packard 5890A gas chromalograph. The GC condilions wcrc 
the Same as for the GC analysis with the cxcplion oi a spiititisj. 
injection. The mass spcctromctcr con&ions wcrc: clcc~ron accclcral- 
ing voliugc, 70 cV; inicrracc tcmpcr?lurc, 170°C; photomul1iplicr 
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voltugc. 400 V: ion source tcmperaturc. 200°C (El) and lYl_PC (PCI): 
trap current, 150 MA (El); emission current, 150 PA (PCI), PCI-MS 
was pcrformcd using isobutane as a reactant gas. 
The subjects were 50.day-old male Wistar rats (ST strain. Shizuoka 
Laboratory Animals. Japan) weighing 215-23.5 g at the time ofexperi- 
mums. The animals were housed at 22.0 2 0S”C in a humidity con- 
trolled room under a 12-h light-dark cycle (lights on et OS:00 h) and 
were allowed food and war ad libitum. 
The perfusion of rat brain by 0.9% NuCl solution was carried out 
under pentobarbital anesthesia (40 mgkg, i.p.) IO eliminate con- 
tamination by amino acids in the blood. The perfused brain tissue. 
which contains tclencephalon, dienccphulon and midbrain was dis- 
sected out on ice and stored at -SO”C until use. 
After the addition of L-NL its an internal standard, the perfused 
tissue was homogenized at 4°C in 5 vols of 5% TCA and 111~ homog. 
enate was ccntrifugcd at IS 000 xg for 30 min at 4°C. To remove TCA. 
the supcrnatant was washed thretilimcs with water-saturarcd diethyl 
ether. The aqueous layer was then passed through a Milliporc lilter. 
HV (0.45 mm) und stored at -8O’C until derivatizetion. 
The 5% TCA extruct was evaporated under a gentle stream of 
nitrogen gas at room temperature. The last trace of water was removed 
azcotropically using mahylcne chloride. The residue was dissolved in 
2 ml of isopropnnol-2N HCI. After lbc mixture was heated at 100°C 
for I h. the excess reagent and solvent were removed under a gentle 
stream of nitrogen gas ill room lemperaiurc. 400 PI of methylene 
chloride and IO0 PI of PFPA were added to the residue, which was 
heated at 100°C for 20 min, The excess reagent and solvent were rkn 
evaporated under a gentle stream of nitrogen grs at room temperature. 
Alicr addition of 2 ml distilled waler. the derivatizcd sample was 
extracted three-times with ethyl acetate. To remove any trace amount 
of water in the combined ethyl acctaic extract, an appropriate amount 
of dry sodium sulfate was added to the combined extract and allowed 
(al 
0 
ui 
(min) 
X- 
to stand for 20 min. After filtrating, the extract was carefully evap 
orttcd in the same way. Finally, the dcrivatized sample was dissolved 
in an appropriate volume of ethyl ucctatc and stored at 4°C until 
analysis. l-2 ~1 of tbc solution was injected into the gds chromut- 
ograph. 
The conccntr;ltions of amino acids (AA) in samples were dcter- 
mined as follows: 
AA @mol/g wet WI,) = (AA area/L-NL arcn in sumplc) x (L-NL 
area/AA area in standard) x wmol L-NL added/g wet wt. of sample). 
3, RESULTS 
Fig. la and Table I show a representative chromat- 
ogram and retention times of N,O-PFP-isopropyl 
standard amino acid derivatives. N,U-PFP-isopropyl 
amino acid derivatives gave good resolution for most of 
the amino acid enantiomers and non-chiral amino acids 
such as glycine, p-alanine and y-aminobutyric acid. Fig. 
lb shows a typical chromatogram of N,O-PFP-iso- 
propyl free amino acid derivatives in the rat brain ex- 
tracts. As can be seen, a peak X at Il.5 min, which 
co-eluted with the D-serine derivative, was detected in 
the brain extracts. In addition, only trace amounts of 
D-alanine and D-aspartic acid were detected in the 
brain extracts (data not shown). 
In principle, the determination of D-amino acids by 
GC alone may be falsified by a compound with the same 
retention time as one of the unknown compounds in the 
rat brain. To confirm the presence of free D-serine in 
lb) 
imln) 
Fig. I. Gas chromatograms of N,O-PFP-isopropyl derivatives of standard amino acids (a) and tiw amino acids in the brain extracts (b). 
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Table I Table ii 
Retention times of N.O-PFP-isopropyl derivatives of nandord amino 
ttcids injected on ;i Chirasil-L-Val capillury column 
The concentration of free D-scrinc and the ratio of f’rcc D-scrinc/~otal 
free scrinc in the rat brain extracts 
Amino acids 
Alaninc 
Valinc 
Thrconinc 
lsoleucine 
Prolinc 
Serinc 
Cyst&c acid 
Leucinr 
Norleucinc (IS.) 
0-Phosphocthanolaminc 
Glycinc 
/?-Alsninc 
GABA 
Retention time (min) 
D L 
’ 3.63 4.32 
5.41 6.15 
626 7.00 
7.37 9.20 
997 IO.22 
11.50 I?,34 
12.63 13.80 
10.41 1238 
13.37 
6.04 
7.15 
8.02 
16.00 
Concentration @mollg wet wcighl) 
D-serinc L-scrine Total serinc 
0.27 z 0.01 0.89 2 0.02 I.16 + 0.03 0.23 P 0.01 
Vnlucs ure expressed as mcsns k SEM of 5 samples. 
tlx rat brain, we performed GC-MS analysis of the peak 
X on the chromatogram obtained from the brain 
samples. Fig. 2a and b show the EI mass spectra of the 
N,O-PFP-isopropyl derivative of authentic D-serine (a) 
and the peak X in the brain extracts (b). The El mass 
spectrum of the peak X, which showed a base peak ion 
at m/z 189, [CH2CHNHCOCF2CF3]+ and 2 weak frag- 
ment ions at m/z 352, [M-COOCH(CH3)1]+ and m/z 380 
[M-OCH(CH,),]‘, was almost identical to that of the 
authentic D-serine. Furthermore, the PC1 mass 
spectrum of the peak X showed a quasimolecular ion at 
rniz 440 [M+ I]+, which was identical to that of the au- 
thentic D-serine (data not shown). Consequently, the 
peak X was identified as D-serine. 
The concentration of free IS-serine in the brain ex- 
tract was estimated to be 0.27 1- 0.01 ,umoYg of wet wt. 
and the ratio of free D-serine/total scrine was 0.23 f 
0.01 (Table II). The concentrations of amino acids in 
brain extracts uch as total serine, L-alanine and glycine 
were 1.16 1- 0.03, 0.57 2 0.03 and 0.79 f 0.02 umollg 
wet wt.), respectively, which were in accordance with 
those of previous results [13]. 
racemized from the L-form during the assay process. 
This is, however, unlikely because a previous report 
indicated that there is no detectable amount of 
racemization of amino acids under similar assay condi- 
tions [lo]. Indeed, no racemization of L-serine was ob- 
served during the present derivatization process (data 
not shown). The fact that a similar content of free D- 
serine in rat brain was confirmed using HPLC analysis 
following dcrivatization with U-phthalaldehyde and 
Boc-L-cysteine (unpublished ata) also argues against 
the possibility that the presence of D-scrine in the brain 
extracts is due to an artifact. 
The concentration of free D-serine appears to be 
higher than those of the other free D-amino acids ever 
determined in mammalian brain tissues. Free neutral 
amino acids have been shown to be present in mice and 
human brains at the amounts of 0.063 pmol/g of wet wt. 
and 0.012 ,umoVg of wet wt., respectively [8,9]. Al- 
though the brain of a newborn rat contains a much 
higher level of free D-aspartate (0.164 pmol/g of wet 
wt.) than that of the adult rat (0.013 PmoVg of wet wt.) 
[11,12], the free aspartate content of the neonatal rat 
brain is still lower than the free D-serine content in the 
present study. 
The origin and metabolizing systems of free D-serine 
in the brain are not yet known. The transport of neutral 
4. DISCUSSlON 
The present results demonstrate that peak X, which 
exhibited the identical retention time as the NO-PFP- 
isopropyl authentic D-serine derivative, is detected in 
the rat brain samples and that the EI and PC1 mass 
spectra of the peak X of the brain extracts were identical 
to those of the authentic D-serine derivative. These find- 
ings indicated that a considerable amount of the free 
D_CI”I*:_-n.. ,IPIILIv,,I*I of SCII.IC I.&A.YIU..~ “II”.” L.. C.._ ns:na nntl...~ll,, .-.~.-.,,PE *n thca brain of ._I.. 
a mature rat. 
The possibility cannot be excluded that a part of the 
free D-serine detected in the present study would be 
Fig. 2. Electron impact mass spectra ofN.t?-PEP-isopropyl derivative 
of authentic D-serine (t) and the peak X in the brain cxtrdcls (b) 
injcctcd on a Chit&l-L-W capillary column. 
Ratio 
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amino acids such as glycine. serine and alanine through 
the blood-brain barrier is slow [ l4,15] and the D-forms 
were less permeable than the L-forms [ 161. In addition, 
the D-enantiomers of free neutral amino acids are con- 
sidered to be catalyzed in the liver and kidneys and are 
excreted into the urine [17]. These observations sup 
gested that free D-serine in rat brain may not be derived 
from the diet. 
It has been well established that D-serine is a potent 
and selective allosteric agonist for the NMDA-receptor 
complex [l-3]. Thus, like glycine, the D-amino acid is 
IOO-times more potent than the L-isomer in displacing 
[-1H]glycinc binding to the allosteric regulation site. In 
contrast, D-serine has a lower affinity for the inhibitory 
glycinc receptor than L-serine [IS]. It has been generally 
accepted that the D-enantiomers of amino acids are 
assumed to be selectively excluded from a source of 
proteins [19]. Taken together, it is proposed that free 
D-scrine in brain tissues might be a novel candidate of 
an endogenous neurotransmitter for the strychnine-in- 
sensitive glycine binding site associated with the 
NMDA-receptor complex. 
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